Recruitment strategies and participant motivations in a digital randomized controlled trial for the prevention of anxiety disorders: the prevANS study - Top-Institutions - MDSpire

Recruitment strategies and participant motivations in a digital randomized controlled trial for the prevention of anxiety disorders: the prevANS study

  • By

  • Cristina García-Huércano

  • Sonia Conejo-Cerón

  • Alberto Rodríguez-Morejón

  • Carmela Martínez-Vispo

  • Natalia Sánchez-Aguadero

  • Olaya Tamayo-Morales

  • Patricia Moreno-Peral

  • May 13, 2026

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Psychiatry
    • Digital Mental Health

  • #2

    NewYork-Presbyterian Hospital–Columbia and Cornell
    NewYork-Presbyterian Hospital–Columbia and Cornell

    New York, New York

    Key Differentiators

    • Psychiatry
    • Anxiety Disorders

  • #3

    Charité—Universitätsmedizin Berlin
    Charité—Universitätsmedizin Berlin

    Berlin, Germany

    Key Differentiators

    • Psychiatry

  • #4

    Deutsches Herzzentrum Berlin
    Deutsches Herzzentrum Berlin

    Berlin, Germany

    Key Differentiators

    • Psychiatry

  • #5

    University of Sydney
    University of Sydney

    Sydney, Australia

    Key Differentiators

    • Psychiatry

Original Source(s)

Recruitment strategies and participant motivations in a digital randomized controlled trial for the prevention of anxiety disorders: the prevANS study

  • by Cristina García-Huércano, Sonia Conejo-Cerón, Alberto Rodríguez-Morejón, Carmela Martínez-Vispo, Natalia Sánchez-Aguadero, Olaya Tamayo-Morales, Patricia Moreno-Peral

  • May 13, 2026

Related Content

Psilocybin for Cocaine Use: Signal or Noise?

Pilot randomized study suggests possible benefit, but blinding concerns and limited generalizability complicate interpretation

Semaglutide Tested in Alcohol Use Disorder

Randomized trial found improvements in alcohol consumption and metabolic outcomes, with gastrointestinal adverse events more common with treatment

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.